Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type II cuticular Hb6 (KRT86) is a **structural protein** encoded by the *KRT86* gene and is a component of the intermediate filaments in the cortex of hair shafts and in other hard keratinized tissues such as nails[1][2][3][5]. This protein heterodimerizes with type I keratins to provide **mechanical strength** and **resilience** to the hair shaft, protecting it from everyday physical stress[2][1]. Mutations in *KRT86* are causative for **monilethrix**, a rare dominantly inherited hair disorder characterized by fragile, beaded hair and sometimes nail abnormalities[1][2][3]. The gene is not considered a classical pharmacological target, as it is a structural cytoskeletal protein rather than an enzyme, receptor, or transporter[1][3][5].
Not applicable; no direct pharmacological targeting reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type II cuticular Hb6 (KRT86).